Attached files

file filename
10-K - FORM 10-K - Sarepta Therapeutics, Inc.d10k.htm
EX-3.4 - AMENDED AND RESTATED BYLAWS OF AVI BIOPHARMA - Sarepta Therapeutics, Inc.dex34.htm
EX-4.1 - FORM OF SPECIMAN CERTIFICATE FOR COMMON STOCK - Sarepta Therapeutics, Inc.dex41.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Sarepta Therapeutics, Inc.dex231.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - Sarepta Therapeutics, Inc.dex312.htm
EX-10.6 - AMENDMENT NO. 2 TO EMPLOYMENT WITH PATRICK IVERSEN, PH.D. - Sarepta Therapeutics, Inc.dex106.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - Sarepta Therapeutics, Inc.dex321.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - Sarepta Therapeutics, Inc.dex311.htm
EX-10.5 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH PATRICK IVERSEN PH.D. - Sarepta Therapeutics, Inc.dex105.htm
EX-10.2 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH DWIGHT WELLER - Sarepta Therapeutics, Inc.dex102.htm
EX-10.3 - AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT WITH DWIGHT WELLER - Sarepta Therapeutics, Inc.dex103.htm
EX-10.15 - EMPLOYMENT AGREEMENT BETWEEN AVI BIOPHARMA AND PAUL MEDEIROS - Sarepta Therapeutics, Inc.dex1015.htm
EX-10.10 - EMPLOYMENT AGREEMENT BETWEEN AVI BIOPHARMA AND DAVID BOYLE II - Sarepta Therapeutics, Inc.dex1010.htm
EX-10.53 - LEASE EXTENSION AND MODIFICATION AGREEMENT - Sarepta Therapeutics, Inc.dex1053.htm
EX-10.12 - AMENDMENT NO.2 TO EMPLOYMENT AGREEMENT WITH J. DAVID BOYLE II - Sarepta Therapeutics, Inc.dex1012.htm
EX-10.11 - AMENDMENT NO.1 TO EMPLOYMENT AGREEMENT BETWEEN AVI BIOPHARMA & J.DAVID BOYLE II - Sarepta Therapeutics, Inc.dex1011.htm
EX-10.17 - EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN AVI BIOPHARMA & CHRISTOPHER GERABEDIAN - Sarepta Therapeutics, Inc.dex1017.htm
EX-10.36 - EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN UNIVERSITY OF WESTERN AUSTRALIA & AVI - Sarepta Therapeutics, Inc.dex1036.htm
EX-10.18 - OFFER LETTER BETWEEN AVI BIOPHARMA, INC. AND GRAHAM JOHNSON B.SC.,PH.D. - Sarepta Therapeutics, Inc.dex1018.htm
EX-10.57 - LEASE BY AND BETWEEN S/I NORTH CREEK VII LLC AND AVI BIOPHARMA - Sarepta Therapeutics, Inc.dex1057.htm
EX-10.16 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH PAUL MEDEIROS - Sarepta Therapeutics, Inc.dex1016.htm
EX-10.14 - AMENDMENT NO.1 TO EMPLOYMENT AGREEMENT WITH STEPHEN BEVAN SHREWSBERRY, M.D. - Sarepta Therapeutics, Inc.dex1014.htm
EX-10.9 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH DR. RYSZARD KOLE - Sarepta Therapeutics, Inc.dex109.htm

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

I, J. David Boyle II, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of AVI BioPharma, Inc. on Form 10-K for the fiscal year ended December 31, 2010, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of AVI BioPharma, Inc.

 

March 14, 2011     /s/ J. David Boyle II
    J. David Boyle II,
    Senior Vice President and Chief Financial Officer
    (Principal Financial and Accounting Officer)

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to AVI BioPharma, Inc. and will be retained by AVI BioPharma, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies this Report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by AVI BioPharma, Inc. for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that AVI BioPharma, Inc. specifically incorporates it by reference.